Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00052637 · ClinicalTrials.gov registry record · Phase 3
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
A Phase 3 study, sponsored by Photocure.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00052637 is a Phase 3 study that has completed, run by Photocure.
The verdict
NCT00052637, a Phase 3 study, has completed, sponsored by Photocure.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have bladder cancer.
Interventions
- PROCEDURE biopsy
- DRUG hexaminolevulinate
- PROCEDURE cystoscopy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00052637
The ClinicalTrials.gov registry entry for NCT00052637 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Photocure, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which biopsy is the first listed.
NCT00052637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00052637 about?
NCT00052637 is a clinical study titled "Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer". RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer and to determine the extent of disease. PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl 5-aminolevulinate and two light sources in detecting carcinoma in situ in patients wh...
What is the current status of trial NCT00052637?
This trial is currently completed. It is a Phase 3 study. The study started on 2001-09.
What interventions are being tested in trial NCT00052637?
The interventions under investigation include: biopsy (PROCEDURE), hexaminolevulinate (DRUG), cystoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT00052637?
This trial is sponsored by Photocure, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.